VRIC aims to identify unmet medical needs for infectious disease vaccines and biomarkers and conduct translational research through a multi-center/multidisciplinary platform.
Functioning as the central laboratory for clinical trials and collaborating with international organizations
Ensuring self-sufficiency and globalization of domestic vaccines and expanding the role of the Ministry of Food and Drug Safety clinical trial specimen analysis institute
Providing and serving as a focal point for infectious disease-related industry, academia, hospitals, and research-associated platform
Bacterial, fungal, and viral domestic molecular epidemiology and pathogenesis
Developing early diagnostic systems using biomarkers and conducting research on source technologies for treatment
Leading the clinical application and commercialization of the cutting edge diagnostic and therapeutic technologies for infectious diseases, including advanced regenerative medicine
Research collaborations